Editorial Comment: Symposium: Tscherne Festschrift: Editorial Comment
نویسندگان
چکیده
منابع مشابه
Editorial Comment: Therapeutic Orphans
By an odd and unfortunate twist of fate, infants and children are becoming “therapeutic or pharmaceutical orphans.”1 Since 1962 they have been denied the use of many new drugs. The Drug Laws of 1962 had their inception following a pediatric tragedy—the thalidomide catastrophe. The laws of 1938 followed another which resulted from the use of a pediatric dosage form, “elixir” of sulfanilamide. By...
متن کاملEditorial comment: The Nuss procedure.
the quality of life in young male adults with pectus excavatum deformity. Nakajima T. Stress distribution on the thorax after the Nuss procedure for pectus excavatum results in different patterns between adult and child patients. Postoperative consumption of opioid analgesics following correction of pectus excavatum is influenced by pectus severity: a single-centre study of 236 patients undergo...
متن کاملComment on Editorial; Best Research for Low Income Countries
Achieving a practical and productive balance in collaborative research between partners from high and lower income countries (North-South Collaborations) requires seeking win-win solutions. This issue requires time to engage each other and to understand each participant’s research priorities and to identify areas of mutual interest. In SACTRC’s experience, key elements include; building researc...
متن کاملEDITORIAL COMMENT Outcomes in Diabetics Undergoing Revascularization
Diabetes mellitus, a major determinant of cardiovascular events, portends an adverse prognosis in patients with coronary artery disease regardless of treatment strategy. Among patients undergoing coronary revascularization procedures, the Bypass Angioplasty Revascularization Investigation (BARI) trial (1) demonstrated an unfavorable interaction between diabetes and an initial strategy of percut...
متن کاملEditorial Comment Can Plasminogen Activators Be Improved?
T he widespread application of plasminogen activators in the treatment of myocardial infarction has resulted in a significant reduction in mortality.",2 Most patients have been treated with two very different drugs: streptokinase, a bacterial protein that is the product of fermentation technology dating from the 1930s, and recombinant tissue-type plasminogen activator (rt-PA), a human protein t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Orthopaedics & Related Research
سال: 2013
ISSN: 0009-921X
DOI: 10.1007/s11999-013-3173-6